Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

During the Trading Day
0.9339 +0.044 / +4.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.9598 +0.0259 / +2.77%
Volume: 500.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues896.0K854.0K854.0K683.0K
Depreciation And Amortization11.0K11.0K11.0K2.0K
Operating ExpensesGross Income----------
General Expenses12.0M9.6M11.5M9.3M
Research And Development6.0M4.5M6.3M5.3M
Total Operating Expenses12.1M9.6M11.5M9.3M
Non-Operating ExpensesOperating Income-11.2M-8.8M-10.6M-8.6M
Extraordinary Charge---89.0K-1.7M-5.3M
Interest Expense On Debt311.0K239.0K233.0K233.0K
Other Expenses10.1M-31.0K3.6M7.1M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3M-9.1M-8.9M-7.0M
Net Income-1.3M-9.1M-8.9M-7.0M
Shares To Calculate EPSShares To Calculate EPS63.0M67.6M72.5M74.8M
Shares To Calculate EPS Diluted63.0M67.6M72.5M74.8M
Earnings Per ShareEPS-$0.02-$0.13-$0.15-$0.09
EPS Diluted-$0.02-$0.13-$0.15-$0.09